ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 12 filers reported holding ACASTI PHARMA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $979,000 | +56.6% | 1,744,236 | -9.3% | 0.00% | 0.0% |
| Q4 2020 | $625,000 | +38.3% | 1,924,000 | +99.9% | 0.00% | – |
| Q2 2020 | $452,000 | +822.4% | 962,593 | +644.8% | 0.00% | – |
| Q1 2020 | $49,000 | -95.8% | 129,246 | -72.5% | 0.00% | -100.0% |
| Q4 2019 | $1,153,000 | +142.7% | 470,664 | +87.5% | 0.00% | – |
| Q3 2019 | $475,000 | +1800.0% | 251,067 | +924.8% | 0.00% | – |
| Q1 2019 | $25,000 | -68.4% | 24,500 | -60.0% | 0.00% | – |
| Q3 2018 | $79,000 | +618.2% | 61,195 | +229.0% | 0.00% | – |
| Q2 2018 | $11,000 | -96.0% | 18,600 | -93.6% | 0.00% | – |
| Q4 2017 | $273,000 | +810.0% | 289,503 | +1252.8% | 0.00% | – |
| Q3 2017 | $30,000 | -16.7% | 21,400 | -21.0% | 0.00% | – |
| Q2 2017 | $36,000 | -36.8% | 27,100 | -34.9% | 0.00% | – |
| Q1 2017 | $57,000 | +1.8% | 41,600 | -7.6% | 0.00% | – |
| Q4 2016 | $56,000 | -11.1% | 45,000 | +27.1% | 0.00% | – |
| Q3 2016 | $63,000 | +46.5% | 35,400 | +14.6% | 0.00% | – |
| Q2 2016 | $43,000 | -6.5% | 30,900 | +1.6% | 0.00% | – |
| Q1 2016 | $46,000 | -13.2% | 30,400 | +45.5% | 0.00% | – |
| Q4 2015 | $53,000 | – | 20,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 236,559 | $594,000 | 0.04% |
| INTACT INVESTMENT MANAGEMENT INC. | 89,490 | $287,000 | 0.01% |
| BANK OF MONTREAL /CAN/ | 210,484 | $537,000 | 0.00% |
| DEUTSCHE BANK AG\ | 215 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 200 | $1,000 | 0.00% |
| CITIGROUP INC | 30 | $0 | 0.00% |
| MORGAN STANLEY | 18 | $0 | 0.00% |
| Renaissance Technologies | 20,900 | $53,000 | 0.00% |
| ROYAL BANK OF CANADA | 588 | $1,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 400 | $1,000 | 0.00% |